Clinical Trials

Study Title:
A Phase II/III Study of Peri operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

For more information about the trial above please contact the study team:

Principal Investigator, Albert Lockhart, at

Study Coordinator, Carly Fecio, at

Trial opened at the following institutions: Medical University of South Carolina